Israel Englander Pfizer Inc Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Pfizer Inc stock. As of the latest transaction made, Millennium Management LLC holds 4,379,700 shares of PFE stock, worth $125 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,379,700

Previous 9,535,483 54.07%

Holding current value

$125 Million

Previous $275 Million 55.73%

% of portfolio

0.05%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $45.5 Million - $52.3 Million	-1,759,324 Reduced 18.45%	7,776,159 $216 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $207 Million - $269 Million	7,921,687 Added 490.87%	9,535,483 $275 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $23.1 Million - $26.7 Million	639,938 Added 65.71%	1,613,796 $59.2 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $5.94 Million - $7.73 Million	-150,750 Reduced 13.4%	973,858 $39.7 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $24.5 Million - $32 Million	-587,233 Reduced 34.3%	1,124,608 $57.6 Million

Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $69.5 Million - $84.8 Million	1,587,540 Added 1277.17%	1,711,841 $74.9 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $157 Million - $186 Million	-3,366,305 Reduced 96.44%	124,301 $6.52 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $37 Million - $45.9 Million	-809,178 Reduced 18.82%	3,490,606 $181 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $21.1 Million - $31.3 Million	-510,935 Reduced 10.62%	4,299,784 $254 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $273,062 - $350,771	6,957 Added 0.14%	4,810,719 $207 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $155 Million - $175 Million	4,307,185 Added 867.38%	4,803,762 $188 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $80.8 Million - $91.1 Million	-2,411,489 Reduced 82.92%	496,577 $18 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $53.1 Million - $67.6 Million	1,587,972 Added 120.29%	2,908,066 $107 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $54 Million - $63.3 Million	-1,699,522 Reduced 56.28%	1,320,094 $48.4 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $6.84 Million - $8.3 Million	-227,020 Reduced 6.99%	3,019,616 $98.7 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $44.9 Million - $64.1 Million	-1,660,092 Reduced 33.83%	3,246,636 $106 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $12.4 Million - $14.1 Million	378,034 Added 8.35%	4,906,728 $192 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $78.1 Million - $101 Million	2,403,579 Added 113.1%	4,528,694 $163 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $29.6 Million - $33.2 Million	800,186 Added 60.39%	2,125,115 $92.1 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $116 Million - $130 Million	-3,134,287 Reduced 70.29%	1,324,929 $29.4 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $125 Million - $137 Million	3,323,196 Added 292.53%	4,459,216 $189 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $37.3 Million - $42.5 Million	968,287 Added 577.28%	1,136,020 $49.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $8.91 Million - $10.8 Million	-258,614 Reduced 60.66%	167,733 $7.39 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $45.4 Million - $48.4 Million	-1,377,676 Reduced 76.37%	426,347 $15.5 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $55.1 Million - $64 Million	-1,727,643 Reduced 48.92%	1,804,023 $64 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $35.7 Million - $37.9 Million	1,074,372 Added 43.72%	3,531,666 $128 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $76.2 Million - $83.9 Million	2,457,294	2,457,294 $87.7 Million

Others Institutions Holding PFE

# of Institutions

3,155

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account